Glennon RA, Misenheimer B (March 1990). "Stimulus properties of a new designer drug: 4-methylaminorex ("U4Euh")". Pharmacology, Biochemistry, and Behavior. 35 (3): 517–21. doi:10.1016/0091-3057(90)90282-M. PMID1971111. S2CID10464868.
Young R (May 1992). "Aminorex produces stimulus effects similar to amphetamine and unlike those of fenfluramine". Pharmacology, Biochemistry, and Behavior. 42 (1): 175–8. doi:10.1016/0091-3057(92)90462-O. PMID1356272. S2CID31002190.
Young R, Glennon RA (May 1993). "Cocaine-stimulus generalization to two new designer drugs: methcathinone and 4-methylaminorex". Pharmacology, Biochemistry, and Behavior. 45 (1): 229–31. doi:10.1016/0091-3057(93)90110-F. PMID8516363. S2CID7648152.
Mansbach RS, Sannerud CA, Griffiths RR, Balster RL, Harris LS (October 1990). "Intravenous self-administration of 4-methylaminorex in primates". Drug and Alcohol Dependence. 26 (2): 137–44. doi:10.1016/0376-8716(90)90120-4. PMID2242714.
Davis FT, Brewster ME (March 1988). "A fatality involving U4Euh, a cyclic derivative of phenylpropanolamine". Journal of Forensic Sciences. 33 (2): 549–53. doi:10.1520/JFS11971J. PMID3373171.
Kankaanpää A, Meririnne E, Ellermaa S, Ariniemi K, Seppälä T (September 2001). "Detection and assay of cis- and trans-isomers of 4-methylaminorex in urine, plasma and tissue samples". Forensic Science International. 121 (1–2): 57–64. doi:10.1016/S0379-0738(01)00453-4. PMID11516888.
Meririnne E, Ellermaa S, Kankaanpää A, Bardy A, Seppälä T (June 2004). "Pharmacokinetics and tissue distribution of the stereoisomers of 4-methylaminorex in the rat". The Journal of Pharmacology and Experimental Therapeutics. 309 (3): 1198–205. doi:10.1124/jpet.103.060053. PMID14742748. S2CID28124406.
Bunker CF, Johnson M, Gibb JW, Bush LG, Hanson GR (May 1990). "Neurochemical effects of an acute treatment with 4-methylaminorex: a new stimulant of abuse". European Journal of Pharmacology. 180 (1): 103–11. doi:10.1016/0014-2999(90)90597-Y. PMID1973111.
Hanson GR, Bunker CF, Johnson M, Bush L, Gibb JW (August 1992). "Response of monoaminergic and neuropeptide systems to 4-methylaminorex: a new stimulant of abuse". European Journal of Pharmacology. 218 (2–3): 287–93. doi:10.1016/0014-2999(92)90181-3. PMID1358636.
Glennon RA, Misenheimer B (March 1990). "Stimulus properties of a new designer drug: 4-methylaminorex ("U4Euh")". Pharmacology, Biochemistry, and Behavior. 35 (3): 517–21. doi:10.1016/0091-3057(90)90282-M. PMID1971111. S2CID10464868.
Young R (May 1992). "Aminorex produces stimulus effects similar to amphetamine and unlike those of fenfluramine". Pharmacology, Biochemistry, and Behavior. 42 (1): 175–8. doi:10.1016/0091-3057(92)90462-O. PMID1356272. S2CID31002190.
Young R, Glennon RA (May 1993). "Cocaine-stimulus generalization to two new designer drugs: methcathinone and 4-methylaminorex". Pharmacology, Biochemistry, and Behavior. 45 (1): 229–31. doi:10.1016/0091-3057(93)90110-F. PMID8516363. S2CID7648152.
Mansbach RS, Sannerud CA, Griffiths RR, Balster RL, Harris LS (October 1990). "Intravenous self-administration of 4-methylaminorex in primates". Drug and Alcohol Dependence. 26 (2): 137–44. doi:10.1016/0376-8716(90)90120-4. PMID2242714.
Davis FT, Brewster ME (March 1988). "A fatality involving U4Euh, a cyclic derivative of phenylpropanolamine". Journal of Forensic Sciences. 33 (2): 549–53. doi:10.1520/JFS11971J. PMID3373171.
Kankaanpää A, Meririnne E, Ellermaa S, Ariniemi K, Seppälä T (September 2001). "Detection and assay of cis- and trans-isomers of 4-methylaminorex in urine, plasma and tissue samples". Forensic Science International. 121 (1–2): 57–64. doi:10.1016/S0379-0738(01)00453-4. PMID11516888.
Meririnne E, Ellermaa S, Kankaanpää A, Bardy A, Seppälä T (June 2004). "Pharmacokinetics and tissue distribution of the stereoisomers of 4-methylaminorex in the rat". The Journal of Pharmacology and Experimental Therapeutics. 309 (3): 1198–205. doi:10.1124/jpet.103.060053. PMID14742748. S2CID28124406.
Bunker CF, Johnson M, Gibb JW, Bush LG, Hanson GR (May 1990). "Neurochemical effects of an acute treatment with 4-methylaminorex: a new stimulant of abuse". European Journal of Pharmacology. 180 (1): 103–11. doi:10.1016/0014-2999(90)90597-Y. PMID1973111.
Hanson GR, Bunker CF, Johnson M, Bush L, Gibb JW (August 1992). "Response of monoaminergic and neuropeptide systems to 4-methylaminorex: a new stimulant of abuse". European Journal of Pharmacology. 218 (2–3): 287–93. doi:10.1016/0014-2999(92)90181-3. PMID1358636.
Glennon RA, Misenheimer B (March 1990). "Stimulus properties of a new designer drug: 4-methylaminorex ("U4Euh")". Pharmacology, Biochemistry, and Behavior. 35 (3): 517–21. doi:10.1016/0091-3057(90)90282-M. PMID1971111. S2CID10464868.
Young R (May 1992). "Aminorex produces stimulus effects similar to amphetamine and unlike those of fenfluramine". Pharmacology, Biochemistry, and Behavior. 42 (1): 175–8. doi:10.1016/0091-3057(92)90462-O. PMID1356272. S2CID31002190.
Young R, Glennon RA (May 1993). "Cocaine-stimulus generalization to two new designer drugs: methcathinone and 4-methylaminorex". Pharmacology, Biochemistry, and Behavior. 45 (1): 229–31. doi:10.1016/0091-3057(93)90110-F. PMID8516363. S2CID7648152.
Meririnne E, Ellermaa S, Kankaanpää A, Bardy A, Seppälä T (June 2004). "Pharmacokinetics and tissue distribution of the stereoisomers of 4-methylaminorex in the rat". The Journal of Pharmacology and Experimental Therapeutics. 309 (3): 1198–205. doi:10.1124/jpet.103.060053. PMID14742748. S2CID28124406.
